» Articles » PMID: 35955598

Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 12
PMID 35955598
Authors
Affiliations
Soon will be listed here.
Abstract

The present study explored the impact of inhibiting α(1,6)fucosylation (core fucosylation) on the functional phenotype of a cellular model of colorectal cancer (CRC) malignization formed by the syngeneic SW480 and SW620 CRC lines. Expression of the gene encoding α(1,6)fucosyltransferase was inhibited in tumor line SW480 by a combination of shRNA-based antisense knockdown and agglutinin (LCA) selection. LCA-resistant clones were subsequently assayed in vitro for proliferation, migration, and adhesion. The α(1,6)FT-inhibited SW480 cells showed enhanced proliferation in adherent conditions, unlike their α(1,6)FT-depleted SW620 counterparts, which displayed reduced proliferation. Under non-adherent conditions, α(1,6)FT-inhibited SW480 cells also showed greater growth capacity than their respective non-targeted control (NTC) cells. However, cell migration decreased in SW480 after knockdown, while adhesion to EA.hy926 cells was significantly enhanced. The reported results indicate that the knockdown strategy with subsequent selection for LCA-resistant clones was effective in greatly reducing α(1,6)FT expression in SW480 and SW620 CRC lines. In addition, α(1,6)FT impairment affected the proliferation, migration, and adhesion of α(1,6)FT-deficient clones SW480 and SW620 in a tumor stage-dependent manner, suggesting that core fucosylation has a dynamic role in the evolution of CRC.

Citing Articles

High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers after Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model.

Lopez-Cortes R, Muinelo-Romay L, Fernandez-Briera A, Gil Martin E J Proteome Res. 2024; 23(4):1379-1398.

PMID: 38507902 PMC: 11002942. DOI: 10.1021/acs.jproteome.3c00833.


The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications.

Shi M, Nan X, Liu B Int J Mol Sci. 2024; 25(2).

PMID: 38256141 PMC: 10815953. DOI: 10.3390/ijms25021068.


Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells.

Lopez-Cortes R, Correa Pardo I, Muinelo-Romay L, Fernandez-Briera A, Gil-Martin E Int J Mol Sci. 2023; 24(15).

PMID: 37569254 PMC: 10418920. DOI: 10.3390/ijms241511879.


FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

Zhang W, Lin W, Zeng X, Zhang M, Chen Q, Tang Y Aging Dis. 2023; 14(5):1927-1944.

PMID: 37196106 PMC: 10529761. DOI: 10.14336/AD.2023.0218.

References
1.
Cheng L, Gao S, Song X, Dong W, Zhou H, Zhao L . Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs. Oncotarget. 2016; 7(38):61199-61214. PMC: 5308645. DOI: 10.18632/oncotarget.11284. View

2.
Doherty M, Theodoratou E, Walsh I, Adamczyk B, Stockmann H, Agakov F . Plasma N-glycans in colorectal cancer risk. Sci Rep. 2018; 8(1):8655. PMC: 5988698. DOI: 10.1038/s41598-018-26805-7. View

3.
Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

4.
Liu D, Gao Z, Yue L . Fucosyltransferase 8 deficiency suppresses breast cancer cell migration by interference of the FAK/integrin pathway. Cancer Biomark. 2019; 25(4):303-311. DOI: 10.3233/CBM-190209. View

5.
Ben Q, An W, Fei J, Xu M, Li G, Li Z . Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells . Exp Ther Med. 2014; 7(4):785-790. PMC: 3961134. DOI: 10.3892/etm.2014.1519. View